Ophthalmic medicine and treatment of diseases and injuries of the cornea

 

The invention relates to medicine, in particular to ophthalmology, and can be used as ophthalmic medicines for the treatment of diseases and injuries of the cornea. The tool includes a glycoprotein and a pharmaceutically acceptable carrier. Glycoprotein isolated from blood serum of mammals isoelectric focusing in a pH gradient with the selection of appropriate fractions, soluble in a saturated (100%) solution of ammonium sulfate has an isoelectric point in the pH range from 4.5 to 5.1 and apparent molecular mass from 10 to 37 kDa and possibly calcium chloride in the following ratio, wt.%: serum glycoprotein 110^-16110^-9; calcium chloride 00,01; media - the rest. The offered product is used by instillation on the cornea of the eye 2-7 fold within 10-15 days, both independently and in combination with other drugs. Ophthalmological tool used in the way that leads to the formation of a more delicate scar the cornea and reduces the risk of severe complications. 2 S. and 9 C.p. f-crystals, 1 Il., 6 table.top:2mm;">Claims

1. Ophthalmic drug, including glycoprotein and a pharmaceutically acceptable carrier, characterized in that it contains as a serum glycoprotein glycoprotein isolated from blood serum of mammals isoelectric focusing in a pH gradient with the selection of appropriate fractions, soluble in a saturated (100%) solution of ammonium sulfate having isoelectric point in the pH range from 4.5 to 5.1 and apparent molecular mass from 10 to 37 kDa and possibly calcium chloride in the following ratio, wt.%:

Serum glycoprotein 110^-16- 110^-9

Calcium chloride 0 - 0,01

Media Else

2. Means under item 1, characterized in that it contains components in the following ratio, wt.%:

Serum glycoprotein 110^-16- 110^-9

Calcium chloride 0,910^-4- 0,01

Media Else

3. Means under item 1, characterized in that as the pharmaceutical carrier contains saline.

4. Means under item 1, characterized in that it contains the components is of LCI chloride 0,910^-4- 1,110^-4

Sodium chloride 0,86 - 0,92

Water To 100

5. The method of treatment of diseases and injuries of the cornea, characterized in that the use of pharmacological tool for PP.1-4 by installations on the cornea of the eye 2-7 fold within 10-15 days.

6. The method of treatment on p. 5, characterized in that used vehicle for PP.1-4 for the treatment of corneal erosion, States after penetrating and layer-by-layer keratoplasty eye, keratitis, burns and eye injuries.

7. The method of treatment on p. 5, characterized in that used vehicle for PP.1-4 in the postoperative period with the aim of improving the outcome of surgery on the eyes.

8. The method of treatment on p. 5, characterized in that used vehicle for PP.1-4 in the preoperative period with the aim of improving the outcome of surgery on the eyes.

9. The method of treatment on p. 5, characterized in that used vehicle for PP.1-4 to resolve adverse effects when wearing contact lenses.

10. The method of treatment on p. 5, characterized in that used vehicle for PP.1-4 to relieve discomfort and eye fatigue.

11. The method of treatment according to PP.5-10, characterized in that the means for PP.1-4 is used in combination with various drugs in video, reparative, anti-inflammatory (steroidal and nonsteroidal), dezintoksikatsionnye, antihistamines, vitamins, diuretics, specific catalysts (chemical burns), antioxidants, enzymes and proteolysis inhibitors, immunomodulators, mydriatic, vasodilator and vasoprotective, interleukins, as well as autohemotherapy.